Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype

doi:10.1083/jcb.132.1.195

This Article

	Full Text (PDF, 14771K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JCB
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Erlebacher, A.
	Articles by Derynck, R.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Erlebacher, A.
	Articles by Derynck, R.


Social Bookmarking

	What's this?

ARTICLES

Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype

A Erlebacher and R Derynck
Department of Growth and Development, University of California at San Francisco 94143, USA.

The development of the skeleton requires the coordinated activities of bone-forming osteoblasts and bone-resorbing osteoclasts. The activities of these two cell types are likely to be regulated by TGF-beta, which is abundant in bone matrix. We have used transgenic mice to evaluate the role of TGF-beta 2 in bone development and turnover. Osteoblast- specific overexpression of TGF-beta 2 from the osteocalcin promoter resulted in progressive bone loss associated with increases in osteoblastic matrix deposition and osteoclastic bone resorption. This phenotype closely resembles the bone abnormalities seen in human hyperparathyroidism and osteoporosis. Furthermore, a high level of TGF- beta 2 overexpression resulted in defective bone mineralization and severe hypoplasia of the clavicles, a hallmark of the developmental disease cleidocranial dysplasia. Our results suggest that TGF-beta 2 functions as a local positive regulator of bone remodeling and that alterations in TGF-beta 2 synthesis by bone cells, or in their responsiveness to TGF-beta 2, may contribute to the pathogenesis of metabolic bone disease.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Nishimura, R. (2009). A Novel Role for TGF-{beta}1 in Bone Remodeling. IBMS BoneKEy 6: 434-438 [Full Text]
Yoshinaga, K., Obata, H., Jurukovski, V., Mazzieri, R., Chen, Y., Zilberberg, L., Huso, D., Melamed, J., Prijatelj, P., Todorovic, V., Dabovic, B., Rifkin, D. B. (2008). Perturbation of transforming growth factor (TGF)-ss1 association with latent TGF-{beta} binding protein yields inflammation and tumors. Proc. Natl. Acad. Sci. USA 105: 18758-18763 [Abstract] [Full Text]
Tan, X., Weng, T., Zhang, J., Wang, J., Li, W., Wan, H., Lan, Y., Cheng, X., Hou, N., Liu, H., Ding, J., Lin, F., Yang, R., Gao, X., Chen, D., Yang, X. (2007). Smad4 is required for maintaining normal murine postnatal bone homeostasis. J. Cell Sci. 120: 2162-2170 [Abstract] [Full Text]
Ofek, O., Karsak, M., Leclerc, N., Fogel, M., Frenkel, B., Wright, K., Tam, J., Attar-Namdar, M., Kram, V., Shohami, E., Mechoulam, R., Zimmer, A., Bab, I. (2006). Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc. Natl. Acad. Sci. USA 103: 696-701 [Abstract] [Full Text]
Balooch, G., Balooch, M., Nalla, R. K., Schilling, S., Filvaroff, E. H., Marshall, G. W., Marshall, S. J., Ritchie, R. O., Derynck, R., Alliston, T. (2005). TGF-{beta} regulates the mechanical properties and composition of bone matrix. Proc. Natl. Acad. Sci. USA 102: 18813-18818 [Abstract] [Full Text]
Janssens, K., ten Dijke, P., Janssens, S., Van Hul, W. (2005). Transforming Growth Factor-{beta}1 to the Bone. Endocr. Rev. 26: 743-774 [Abstract] [Full Text]
Bajayo, A., Goshen, I., Feldman, S., Csernus, V., Iverfeldt, K., Shohami, E., Yirmiya, R., Bab, I. (2005). Central IL-1 receptor signaling regulates bone growth and mass. Proc. Natl. Acad. Sci. USA 102: 12956-12961 [Abstract] [Full Text]
Bi, Y., Stuelten, C. H., Kilts, T., Wadhwa, S., Iozzo, R. V., Robey, P. G., Chen, X.-D., Young, M. F. (2005). Extracellular Matrix Proteoglycans Control the Fate of Bone Marrow Stromal Cells. J. Biol. Chem. 280: 30481-30489 [Abstract] [Full Text]
Gazzerro, E., Pereira, R. C., Jorgetti, V., Olson, S., Economides, A. N., Canalis, E. (2005). Skeletal Overexpression of Gremlin Impairs Bone Formation and Causes Osteopenia. Endocrinology 146: 655-665 [Abstract] [Full Text]
Teitelbaum, S. L. (2004). Postmenopausal osteoporosis, T cells, and immune dysfunction. Proc. Natl. Acad. Sci. USA 101: 16711-16712 [Full Text]
Prime, S.S., Pring, M., Davies, M., Paterson, I.C. (2004). TGF-{beta} SIGNAL TRANSDUCTION IN ORO-FACIAL HEALTH AND NON-MALIGNANT DISEASE (PART I). CROBM 15: 324-336 [Abstract] [Full Text]
Kan, L., Hu, M., Gomes, W. A., Kessler, J. A. (2004). Transgenic Mice Overexpressing BMP4 Develop a Fibrodysplasia Ossificans Progressiva (FOP)-Like Phenotype. Am. J. Pathol. 165: 1107-1115 [Abstract] [Full Text]
McGowan, N. W. A., MacPherson, H., Janssens, K., Van Hul, W., Frith, J. C., Fraser, W. D., Ralston, S. H., Helfrich, M. H. (2003). A Mutation Affecting the Latency-Associated Peptide of TGF{beta}1 in Camurati-Engelmann Disease Enhances Osteoclast Formation in Vitro. J. Clin. Endocrinol. Metab. 88: 3321-3326 [Abstract] [Full Text]
Bonyadi, M., Waldman, S. D., Liu, D., Aubin, J. E., Grynpas, M. D., Stanford, W. L. (2003). Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc. Natl. Acad. Sci. USA 100: 5840-5845 [Abstract] [Full Text]
Devlin, R. D., Du, Z., Pereira, R. C., Kimble, R. B., Economides, A. N., Jorgetti, V., Canalis, E. (2003). Skeletal Overexpression of Noggin Results in Osteopenia and Reduced Bone Formation. Endocrinology 144: 1972-1978 [Abstract] [Full Text]
Morris, M. J., Scher, H. I. (2003). Clinical Approaches to Osseous Metastases in Prostate Cancer. The Oncologist 8: 161-173 [Abstract] [Full Text]
Gurlek, A., Pittelkow, M. R., Kumar, R. (2002). Modulation of Growth Factor/Cytokine Synthesis and Signaling by 1{alpha},25-Dihydroxyvitamin D3: Implications in Cell Growth and Differentiation. Endocr. Rev. 23: 763-786 [Abstract] [Full Text]
Chang, H., Brown, C. W., Matzuk, M. M. (2002). Genetic Analysis of the Mammalian Transforming Growth Factor-{beta} Superfamily. Endocr. Rev. 23: 787-823 [Abstract] [Full Text]
Devlin, R. D., Du, Z., Buccilli, V., Jorgetti, V., Canalis, E. (2002). Transgenic Mice Overexpressing Insulin-Like Growth Factor Binding Protein-5 Display Transiently Decreased Osteoblastic Function and Osteopenia. Endocrinology 143: 3955-3962 [Abstract] [Full Text]
Peacock, M., Turner, C. H., Econs, M. J., Foroud, T. (2002). Genetics of Osteoporosis. Endocr. Rev. 23: 303-326 [Abstract] [Full Text]
Szweras, M., Liu, D., Partridge, E. A., Pawling, J., Sukhu, B., Clokie, C., Jahnen-Dechent, W., Tenenbaum, H. C., Swallow, C. J., Grynpas, M. D., Dennis, J. W. (2002). alpha 2-HS Glycoprotein/Fetuin, a Transforming Growth Factor-beta /Bone Morphogenetic Protein Antagonist, Regulates Postnatal Bone Growth and Remodeling. J. Biol. Chem. 277: 19991-19997 [Abstract] [Full Text]
Abboud, S. L., Woodruff, K., Liu, C., Shen, V., Ghosh-Choudhury, N. (2002). Rescue of the Osteopetrotic Defect in op/op Mice by Osteoblast-Specific Targeting of Soluble Colony-Stimulating Factor-1. Endocrinology 143: 1942-1949 [Abstract] [Full Text]
Karsdal, M. A., Fjording, M. S., Foged, N. T., Delaisse, J.-M., Lochter, A. (2001). Transforming Growth Factor-beta -induced Osteoblast Elongation Regulates Osteoclastic Bone Resorption through a p38 Mitogen-activated Protein Kinase- and Matrix Metalloproteinase-dependent Pathway. J. Biol. Chem. 276: 39350-39358 [Abstract] [Full Text]
DenBesten, P.K., Machule, D., Gallagher, R., Marshall, G. W. Jr, Mathews, C., Filvaroff, E. (2001). The Effect of TGF-{beta}2 on Dentin Apposition and Hardness in Transgenic Mice. ADR 15: 39-41 [Abstract]
Itoh, K., Udagawa, N., Katagiri, T., Iemura, S., Ueno, N., Yasuda, H., Higashio, K., Quinn, J. M. W., Gillespie, M. T., Martin, T. J., Suda, T., Takahashi, N. (2001). Bone Morphogenetic Protein 2 Stimulates Osteoclast Differentiation and Survival Supported by Receptor Activator of Nuclear Factor-{kappa}B Ligand. Endocrinology 142: 3656-3662 [Abstract] [Full Text]
Aguirre, J., Buttery, L., O'Shaughnessy, M., Afzal, F., Fernandez de Marticorena, I., Hukkanen, M., Huang, P., MacIntyre, I., Polak, J. (2001). Endothelial Nitric Oxide Synthase Gene-Deficient Mice Demonstrate Marked Retardation in Postnatal Bone Formation, Reduced Bone Volume, and Defects in Osteoblast Maturation and Activity. Am. J. Pathol. 158: 247-257 [Abstract] [Full Text]
Pereira, R. C., Economides, A. N., Canalis, E. (2000). Bone Morphogenetic Proteins Induce Gremlin, a Protein That Limits Their Activity in Osteoblasts. Endocrinology 141: 4558-4563 [Abstract] [Full Text]
Kaneda, T., Nojima, T., Nakagawa, M., Ogasawara, A., Kaneko, H., Sato, T., Mano, H., Kumegawa, M., Hakeda, Y. (2000). Endogenous Production of TGF-{beta} Is Essential for Osteoclastogenesis Induced by a Combination of Receptor Activator of NF-{kappa}B Ligand and Macrophage-Colony- Stimulating Factor. J. Immunol. 165: 4254-4263 [Abstract] [Full Text]
Fuller, K, Lean, J., Bayley, K., Wani, M., Chambers, T. (2000). A role for TGFbeta(1) in osteoclast differentiation and survival. J. Cell Sci. 113: 2445-2453 [Abstract]
Karsenty, G. (1999). The genetic transformation of bone biology. Genes Dev. 13: 3037-3051 [Full Text]
Binkert, C., Demetriou, M., Sukhu, B., Szweras, M., Tenenbaum, H. C., Dennis, J. W. (1999). Regulation of Osteogenesis by Fetuin. J. Biol. Chem. 274: 28514-28520 [Abstract] [Full Text]
Filvaroff, E, Erlebacher, A, Ye, J, Gitelman, S., Lotz, J, Heillman, M, Derynck, R (1999). Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development 126: 4267-4279 [Abstract]
Erlebacher, A., Filvaroff, E. H., Ye, J.-Q., Derynck, R. (1998). Osteoblastic Responses to TGF-beta during Bone Remodeling. Mol. Biol. Cell 9: 1903-1918 [Abstract] [Full Text]
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., Boyle, W. J., Simonet, W. S. (1998). osteoprotegerin-deficient mice develop early onset osteoporosis and arterial�calcification. Genes Dev. 12: 1260-1268 [Abstract] [Full Text]
Chang, D. J., Ji, C., Kim, K. K., Casinghino, S., McCarthy, T. L., Centrella, M. (1998). Reduction in Transforming Growth Factor beta �Receptor I Expression and Transcription Factor CBFa1 on Bone Cells by Glucocorticoid. J. Biol. Chem. 273: 4892-4896 [Abstract] [Full Text]
Guise, T. A., Mundy, G. R. (1998). Cancer and Bone. Endocr. Rev. 19: 18-54 [Abstract] [Full Text]
Pilbeam, C., Rao, Y., Voznesensky, O., Kawaguchi, H., Alander, C., Raisz, L., Herschman, H. (1997). Transforming Growth Factor-{beta}1 Regulation of Prostaglandin G/H Synthase-2 Expression in Osteoblastic MC3T3-E1 Cells. Endocrinology 138: 4672-4682 [Abstract] [Full Text]
Murakami, S., Nifuji, A., Noda, M. (1997). Expression of Indian Hedgehog in Osteoblasts and Its Posttranscriptional Regulation by Transforming Growth Factor-{beta}. Endocrinology 138: 1972-1978 [Abstract] [Full Text]
Hefferan, T. E., Reinholz, G. G., Rickard, D. J., Johnsen, S. A., Waters, K. M., Subramaniam, M., Spelsberg, T. C. (2000). Overexpression of a Nuclear Protein, TIEG, Mimics Transforming Growth Factor-beta Action in Human Osteoblast Cells. J. Biol. Chem. 275: 20255-20259 [Abstract] [Full Text]
Dabovic, B., Chen, Y., Colarossi, C., Obata, H., Zambuto, L., Perle, M. A., Rifkin, D. B. (2002). Bone abnormalities in latent TGF-{beta} binding protein (Ltbp)-3-null mice indicate a role for Ltbp-3 in modulating TGF-{beta} bioavailability. JCB 156: 227-232 [Abstract] [Full Text]